Lucite tombstone celebrating the launch by Palo Alto-based Institutional Ventue Partners of its 18th fund. The fund will focus on technology sectors such as artificial intelligence (AI), fintech, SaaS, and enterprise infrastructure. (24ALJ047)
Lucite tombstone celebrating the launch by Palo Alto-based Institutional Ventue Partners of its 18th fund. The fund will focus on technology sectors such as artificial intelligence (AI), fintech, SaaS, and enterprise infrastructure. (24ALJ047)
Custom crystal commemorating the successful closing of multiple technology-focused funds by the private equity firm Accel-KKR. (23ALJ072)
Crystal deal toy celebrating the close of the inaugural fundraising phase for Blackstone Infrastructure Partners. The fund focuses on infrastructure projects in a range of sectors, including transportation, energy, and communications. (9AKL410)
Crystal deal toy celebrating the successful close of a buyout fund focused on the healthcare and technology sectors. The fund was raised by Kester Capital, a London-based private equity firm specializing in the lower mid-market. (24LJW019)
Crystal financial tombstone celebrating Series A funding for Lokavant. Based in New York, Lokavant provides a centralized data repository for clinical drug trials. (23AKL083)
Crystal deal toy commemorating the close of a single-asset continuation fund by London-based GHO Capital Partners. The single investment is in Valiant, a compliance and regulatory firm, and was led by Goldman Sachs Asset Management, and the Los Angeles County Employees Retirement Association. (22LJW086)
Mill-themed crystal deal toy marking the sale of an investment in Equitix Fund III. The fund invests in both UK and Italy in the areas of social infrastructure, transportation, environmental services, and renewables. (22LJW114)
Custom crystal commemorative marking the launch of a third fund by UK-based, software-focused firm FPE Capital. (22LJW152)
Crystal financial tombstone celebrating the launch of a fund by New York-based healthcare venture capital firm HC9 Ventures. The fund will focus on early-stage healthcare startups. (22AZH168)
